Velpatasvir
ATC — · 10 markets · 36 records
GB 7 records · 4 strengths
- 100 mgtabletEpclusaVosevi、Manufacturer: Gilead Sciences Ltd
- 50 mgtabletEpclusa
- 50 mgpowderEpclusa 200mg/50mg granules sachets
- 37.5 mgpowderEpclusa 200mg/50mg granules sachets
US 6 records · 4 strengths
AU 6 records · 2 strengths
- 100 mgtabletEpclusaEPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle、Vosevi、VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle
Records without a stated strength · 1 Epclusa、Vosevi
ES 6 records · 4 strengths
Records without a stated strength · 1 Vosevi
CA 2 records · 1 strengths
- 100 mgtabletEpclusaVosevi
SG 2 records · 1 strengths
- 100 mgtabletEpclusaVosevi
TW 2 records · 1 strengths
Records without a stated strength · 1 Epclusa、Vosevi、宜譜莎 膜衣錠、沃士維膜衣錠
HK 2 records · 1 strengths
Records without a stated strength · 1 Epclusa、Vosevi
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Epclusa、Vosevi
MX 1 records · 1 strengths
Records without a stated strength · 1 Vosevi
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg tablet | Epclusa Sofosbuvir and Velpatasvir Vosevi | Manufacturer: Gilead Sciences Ltd ×2 Epclusa Vosevi | Epclusa Vosevi | Epclusa EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle Vosevi+1VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle | Epclusa Vosevi | Epclusa | ||||
| 50 mg tablet | Epclusa | Epclusa | ||||||||
| 50 mg liquid | Epclusa | |||||||||
| 37.5 mg liquid | Epclusa | |||||||||
| 50 mg powder | Epclusa 200mg/50mg granules sachets | |||||||||
| 37.5 mg powder | Epclusa 200mg/50mg granules sachets | |||||||||
| 50 mg pellet | Epclusa | |||||||||
| 37.5 mg pellet | Epclusa | |||||||||
tablet | Vosevi | Vosevi | Epclusa Vosevi 宜譜莎 膜衣錠+1沃士維膜衣錠 | |||||||
unknown | Epclusa Vosevi | Epclusa Vosevi | Epclusa Vosevi |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in ES · MX · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en ES · MX · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 ES · MX · TW 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 ES · MX · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.